Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.0497
Delayed Data
As of Jun 30
 +0.0094 / +23.33%
Today’s Change
0.03
Today|||52-Week Range
0.24
-54.57%
Year-to-Date
No recent news for Boston Therapeutics Inc.

Today’s Trading

Previous close0.04
Today’s open0.05
Day’s range0.05 - 0.05
Volume600
Average volume (3 months)37,491
Market cap$1.8M
Dividend yield--
Data as of 12:34pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+266.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-50.43%
P/E ratioNM
Price/Sales43.25
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMarch 31, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$98.9K
Annual profit (last year)-$2.5M
Net profit margin-2,516.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Director, Chief Executive &
Financial Officer
Chi-Heng Cheng
Chief Scientist
Benjamin Rivnay
Corporate headquarters
Newton, Massachusetts

Forecasts

Partner Offers

Search for Jobs